Carsgen Therapeutics | ApexOnco - Clinical Trials news and analysis

x

“I am very impressed - it has become my go-to platform”

Chief Business Officer

US public biotech company

Click here for more information

Magnifying glass resting on computer

Regulatory

29 November 2023

Investors brush off Car-T scare

But the FDA’s investigation looks like worse news for autoimmune disease than oncology.

Regulatory

4 October 2023

The second phase 3 Claudin18.2 asset belongs to Transcenta

Deals

21 August 2023

Moderna gets into Claudin18.2

Subscribe to Carsgen Therapeutics